1. Home
  2. CHE vs APGE Comparison

CHE vs APGE Comparison

Compare CHE & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CHE

Chemed Corp

HOLD

Current Price

$433.06

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Logo Apogee Therapeutics Inc.

APGE

Apogee Therapeutics Inc.

HOLD

Current Price

$80.83

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHE
APGE
Founded
1970
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
4.7B
IPO Year
1994
2023

Fundamental Metrics

Financial Performance
Metric
CHE
APGE
Price
$433.06
$80.83
Analyst Decision
Buy
Strong Buy
Analyst Count
4
13
Target Price
$501.50
$109.67
AVG Volume (30 Days)
193.5K
695.9K
Earning Date
04-23-2026
05-12-2026
Dividend Yield
0.57%
N/A
EPS Growth
N/A
N/A
EPS
4.84
N/A
Revenue
$2,529,978,000.00
N/A
Revenue This Year
$6.56
N/A
Revenue Next Year
$6.23
N/A
P/E Ratio
$90.74
N/A
Revenue Growth
4.06
N/A
52 Week Low
$365.21
$34.34
52 Week High
$572.23
$95.32

Technical Indicators

Market Signals
Indicator
CHE
APGE
Relative Strength Index (RSI) 58.18 47.84
Support Level $423.89 $80.52
Resistance Level $455.83 $86.42
Average True Range (ATR) 11.55 4.54
MACD -0.83 -0.34
Stochastic Oscillator 68.65 44.24

Price Performance

Historical Comparison
CHE
APGE

About CHE Chemed Corp

Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Share on Social Networks: